# Legacy Housing Corp: financial statements, quarterly

LEGH · Nasdaq · CIK 1436208 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/legh.md) · [Financials](/companies/legh/financials.md) · [Filings](/companies/legh/filings.md) · [Insiders](/companies/legh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/legh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q1 FY2033 (2033-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [22.6 d](/filings/0001558370-25-002822.md) | [30.8](/filings/0001558370-25-007424.md) | [31.7](/filings/0001558370-25-010800.md) | [30.2](/filings/0001104659-25-108551.md) | [36.7 d](/filings/0001104659-26-027133.md) | [24.3](/filings/0001104659-26-057062.md) | [38.4](/filings/0001104659-26-091072.md) | [28.8](/filings/0001104659-25-108551.md) | [25.5 d](/filings/0001104659-26-027133.md) | [21.6](/filings/0001104659-26-057062.md) | [53.8](/filings/0001104659-26-091072.md) | not reported |
| Cost of revenue | $m | [16.2 d](/filings/0001558370-25-002822.md) | [20.5](/filings/0001558370-25-007424.md) | [21.6](/filings/0001558370-25-010800.md) | [21.4](/filings/0001104659-25-108551.md) | [26.7 d](/filings/0001104659-26-027133.md) | [17.2](/filings/0001104659-26-057062.md) | [25.9](/filings/0001104659-26-091072.md) | [23.0](/filings/0001104659-25-108551.md) | [18.7 d](/filings/0001104659-26-027133.md) | [14.9](/filings/0001104659-26-057062.md) | [33.5](/filings/0001104659-26-091072.md) | not reported |
| Selling, general and administrative | $m | [7.2 d](/filings/0001558370-25-002822.md) | [5.9](/filings/0001558370-25-007424.md) | [5.6](/filings/0001558370-25-010800.md) | [6.1](/filings/0001104659-25-108551.md) | [4.8 d](/filings/0001104659-26-027133.md) | [6.4](/filings/0001104659-26-057062.md) | [5.7](/filings/0001104659-26-091072.md) | [7.3](/filings/0001104659-25-108551.md) | [9.4 d](/filings/0001104659-26-027133.md) | [5.8](/filings/0001104659-26-057062.md) | [6.9](/filings/0001104659-26-091072.md) | not reported |
| Operating income | $m | [9.7 d](/filings/0001558370-25-002822.md) | [16.8](/filings/0001558370-25-007424.md) | [16.0](/filings/0001558370-25-010800.md) | [15.3](/filings/0001104659-25-108551.md) | [15.5 d](/filings/0001104659-26-027133.md) | [11.6](/filings/0001104659-26-057062.md) | [16.8](/filings/0001104659-26-091072.md) | [9.7](/filings/0001104659-25-108551.md) | [10.3 d](/filings/0001104659-26-027133.md) | [12.4](/filings/0001104659-26-057062.md) | [26.5](/filings/0001104659-26-091072.md) | not reported |
| Interest expense | $m | [0.3 d](/filings/0001558370-24-003435.md) | [0.3](/filings/0001558370-24-007647.md) | [0.2](/filings/0001558370-25-010800.md) | [0.2](/filings/0001104659-25-108551.md) | [0.0 d](/filings/0001104659-26-027133.md) | [0.0](/filings/0001104659-26-057062.md) | [0.0](/filings/0001104659-26-091072.md) | [(0.0)](/filings/0001104659-25-108551.md) | [0.0 d](/filings/0001104659-26-027133.md) | [0.0](/filings/0001104659-26-057062.md) | [0.0](/filings/0001104659-26-091072.md) | not reported |
| Income tax | $m | [4.4 d](/filings/0001558370-25-002822.md) | [3.4](/filings/0001558370-25-007424.md) | [3.6](/filings/0001558370-25-010800.md) | [3.5](/filings/0001104659-25-108551.md) | [3.9 d](/filings/0001104659-26-027133.md) | [2.5](/filings/0001104659-26-057062.md) | [3.1](/filings/0001104659-26-091072.md) | [1.6](/filings/0001104659-25-108551.md) | [2.6 d](/filings/0001104659-26-027133.md) | [2.1](/filings/0001104659-26-057062.md) | [3.0](/filings/0001104659-26-091072.md) | [3.4](/filings/0001558370-24-007647.md) |
| Net income | $m | [7.1 d](/filings/0001558370-25-002822.md) | [15.1](/filings/0001104659-25-108551.md) | [16.2](/filings/0001104659-25-108551.md) | [15.8](/filings/0001104659-25-108551.md) | [14.5 d](/filings/0001104659-26-027133.md) | [10.3](/filings/0001104659-26-091072.md) | [14.7](/filings/0001104659-26-091072.md) | [8.6](/filings/0001104659-25-108551.md) | [8.2 d](/filings/0001104659-26-027133.md) | [10.9](/filings/0001104659-26-091072.md) | [23.5](/filings/0001104659-26-091072.md) | not reported |
| Diluted EPS | $ per share | not reported | [0.60](/filings/0001558370-25-007424.md) | [0.65](/filings/0001558370-25-010800.md) | [0.64](/filings/0001104659-25-108551.md) | not reported | [0.41](/filings/0001104659-26-057062.md) | [0.60](/filings/0001104659-26-091072.md) | [0.35](/filings/0001104659-25-108551.md) | not reported | [0.46](/filings/0001104659-26-057062.md) | [0.99](/filings/0001104659-26-091072.md) | not reported |
| Basic EPS | $ per share | not reported | [0.62](/filings/0001558370-25-007424.md) | [0.67](/filings/0001558370-25-010800.md) | [0.65](/filings/0001104659-25-108551.md) | not reported | [0.43](/filings/0001104659-26-057062.md) | [0.61](/filings/0001104659-26-091072.md) | [0.36](/filings/0001104659-25-108551.md) | not reported | [0.46](/filings/0001104659-26-057062.md) | [0.99](/filings/0001104659-26-091072.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.5](/filings/0001558370-23-018606.md) | [0.7](/filings/0001558370-25-002822.md) | [0.6](/filings/0001558370-24-007647.md) | [0.1](/filings/0001558370-24-011633.md) | [0.6](/filings/0001558370-24-015339.md) | [1.1](/filings/0001104659-26-027133.md) | [3.4](/filings/0001558370-25-007424.md) | [2.6](/filings/0001558370-25-010800.md) | [13.6](/filings/0001104659-25-108551.md) | [8.5](/filings/0001104659-26-091072.md) | [14.1](/filings/0001104659-26-057062.md) | [29.0](/filings/0001104659-26-091072.md) |
| Current assets | $m | [95.1](/filings/0001558370-23-018606.md) | [116](/filings/0001558370-25-002822.md) | [146](/filings/0001558370-24-007647.md) | [139](/filings/0001558370-24-011633.md) | [112](/filings/0001558370-24-015339.md) | [124](/filings/0001104659-26-027133.md) | [131](/filings/0001558370-25-007424.md) | [125](/filings/0001558370-25-010800.md) | [173](/filings/0001104659-25-108551.md) | [165](/filings/0001104659-26-091072.md) | [174](/filings/0001104659-26-057062.md) | [181](/filings/0001104659-26-091072.md) |
| Total assets | $m | [496](/filings/0001558370-23-018606.md) | [507](/filings/0001558370-25-002822.md) | [510](/filings/0001558370-24-007647.md) | [515](/filings/0001558370-24-011633.md) | [521](/filings/0001558370-24-015339.md) | [534](/filings/0001104659-26-027133.md) | [545](/filings/0001558370-25-007424.md) | [552](/filings/0001558370-25-010800.md) | [558](/filings/0001104659-25-108551.md) | [580](/filings/0001104659-26-091072.md) | [591](/filings/0001104659-26-057062.md) | [616](/filings/0001104659-26-091072.md) |
| Current liabilities | $m | [44.0](/filings/0001558370-23-018606.md) | [37.3](/filings/0001558370-25-002822.md) | [38.9](/filings/0001558370-24-007647.md) | [31.7](/filings/0001558370-24-011633.md) | [32.4](/filings/0001558370-24-015339.md) | [32.7](/filings/0001104659-26-027133.md) | [33.4](/filings/0001558370-25-007424.md) | [31.7](/filings/0001558370-25-010800.md) | [30.1](/filings/0001104659-25-108551.md) | [46.9](/filings/0001104659-26-091072.md) | [48.5](/filings/0001104659-26-057062.md) | [51.0](/filings/0001104659-26-091072.md) |
| Total liabilities | $m | [66.2](/filings/0001558370-23-018606.md) | [70.0](/filings/0001558370-25-002822.md) | [59.6](/filings/0001558370-24-007647.md) | [51.7](/filings/0001558370-24-011633.md) | [42.1](/filings/0001558370-24-015339.md) | [40.2](/filings/0001104659-26-027133.md) | [40.9](/filings/0001558370-25-007424.md) | [39.2](/filings/0001558370-25-010800.md) | [36.3](/filings/0001104659-25-108551.md) | [51.7](/filings/0001104659-26-091072.md) | [52.5](/filings/0001104659-26-057062.md) | [53.4](/filings/0001104659-26-091072.md) |
| Shareholders' equity | $m | [429](/filings/0001558370-24-015339.md) | [437](/filings/0001104659-26-027133.md) | [450](/filings/0001104659-25-108551.md) | [463](/filings/0001104659-25-108551.md) | [479](/filings/0001104659-25-108551.md) | [494](/filings/0001104659-26-091072.md) | [504](/filings/0001104659-26-091072.md) | [513](/filings/0001104659-26-091072.md) | [522](/filings/0001104659-25-108551.md) | [529](/filings/0001104659-26-091072.md) | [539](/filings/0001104659-26-091072.md) | [562](/filings/0001104659-26-091072.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.2 d](/filings/0001558370-24-015339.md) | [(8.3) d](/filings/0001558370-25-002822.md) | [10.8](/filings/0001558370-25-007424.md) | [3.5 d](/filings/0001558370-25-010800.md) | [13.8 d](/filings/0001104659-25-108551.md) | [7.9 d](/filings/0001104659-26-027133.md) | [4.9](/filings/0001104659-26-057062.md) | [6.1 d](/filings/0001104659-26-091072.md) | [7.2 d](/filings/0001104659-25-108551.md) | [19.0 d](/filings/0001104659-26-027133.md) | [7.0](/filings/0001104659-26-057062.md) | [17.4 d](/filings/0001104659-26-091072.md) |
| Capital expenditure | $m | [3.0 d](/filings/0001558370-24-015339.md) | [3.1 d](/filings/0001558370-25-002822.md) | [0.9](/filings/0001558370-25-007424.md) | [1.7 d](/filings/0001558370-25-010800.md) | [4.7 d](/filings/0001104659-25-108551.md) | [1.9 d](/filings/0001104659-26-027133.md) | [1.3](/filings/0001104659-26-057062.md) | [2.4 d](/filings/0001104659-26-091072.md) | [2.0 d](/filings/0001104659-25-108551.md) | [3.3 d](/filings/0001104659-26-027133.md) | [1.5](/filings/0001104659-26-057062.md) | [5.1 d](/filings/0001104659-26-091072.md) |
| Share repurchases | $m | not reported | not reported | [1.9](/filings/0001558370-25-007424.md) | [3.5](/filings/0001558370-24-011633.md) | [0.0](/filings/0001558370-24-015339.md) | [0.0 d](/filings/0001104659-26-027133.md) | [0.7](/filings/0001104659-26-091072.md) | [5.8](/filings/0001104659-26-091072.md) | [(0.0) d](/filings/0001104659-25-108551.md) | [1.1](/filings/0001104659-26-091072.md) | [0.6](/filings/0001104659-26-057062.md) | [0.1 d](/filings/0001104659-26-091072.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.4](/filings/0001558370-23-018606.md) | [25.2](/filings/0001558370-24-007647.md) | [25.1](/filings/0001558370-24-011633.md) | [25.1](/filings/0001558370-24-015339.md) | [25.1](/filings/0001558370-25-007424.md) | [24.8](/filings/0001558370-25-010800.md) | [24.8](/filings/0001104659-25-108551.md) | [24.8](/filings/0001104659-26-057062.md) | [24.6](/filings/0001104659-26-091072.md) | [24.4](/filings/0001104659-25-108551.md) | [23.8](/filings/0001104659-26-057062.md) | [23.8](/filings/0001104659-26-091072.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,781,601 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091072.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.